Literature DB >> 20849323

How common are behavioural changes in amyotrophic lateral sclerosis?

Patricia Lillo1, Eneida Mioshi, Margaret C Zoing, Matthew C Kiernan, John R Hodges.   

Abstract

Our objectives were to assess the frequency of behavioural changes in patients with amyotrophic lateral sclerosis (ALS) and to compare the clinical profile of ALS patients with those with behavioural variant frontotemporal dementia (bvFTD). Ninety-two patients with ALS and their carers participated in a postal survey. ALS patients completed self-report measures of motor function and mood. Eighty-one carers of ALS patients and 25 carers of bvFTD patients completed the revised version of the Cambridge Behavioural Inventory (CBI-R). Results showed that reduced motivation was reported in more than 80% of the ALS cases, with almost 41% of them having moderate-severe apathy. Depression was present in 30% of ALS patients and did not contribute significantly to the presence of behavioural symptoms. Bulbar and limb onset ALS patients did not differ. Abnormal behaviour and stereotypical and motor behaviours were present to a moderate-severe degree in around 20%, and 11% reached the criteria for FTD. The rate of behavioural symptoms was significantly higher in the bvFTD group than ALS in all behavioural domains (p <0.001). In conclusion, apathy was the most prominent feature in ALS patients. A substantial proportion of ALS patients manifested behavioural changes of the type seen in FTD, with 11% fulfilling the criteria for FTD.

Entities:  

Mesh:

Year:  2010        PMID: 20849323     DOI: 10.3109/17482968.2010.520718

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  52 in total

1.  Personality disturbances in amyotrophic lateral sclerosis: a case study demonstrating changes in personality without cognitive deficits.

Authors:  Eric J Waldron; Joseph Barrash; Andrea Swenson; Daniel Tranel
Journal:  J Int Neuropsychol Soc       Date:  2014-05-23       Impact factor: 2.892

2.  Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors.

Authors:  Tom Burke; Marwa Elamin; Miriam Galvin; Orla Hardiman; Niall Pender
Journal:  J Neurol       Date:  2015-04-23       Impact factor: 4.849

3.  Body mass index delineates ALS from FTD: implications for metabolic health.

Authors:  R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

Review 4.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Frontotemporal cortical thinning in amyotrophic lateral sclerosis.

Authors:  A d'Ambrosio; A Gallo; F Trojsi; D Corbo; F Esposito; M Cirillo; M R Monsurrò; G Tedeschi
Journal:  AJNR Am J Neuroradiol       Date:  2013-10-10       Impact factor: 3.825

Review 6.  Modeling ALS and FTD with iPSC-derived neurons.

Authors:  Sebum Lee; Eric J Huang
Journal:  Brain Res       Date:  2015-10-14       Impact factor: 3.252

7.  Pathological staging of frontotemporal lobar degeneration.

Authors:  Jillian J Kril; Glenda M Halliday
Journal:  J Mol Neurosci       Date:  2011-05-07       Impact factor: 3.444

Review 8.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

9.  Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.

Authors:  Tom Burke; Orla Hardiman; Marta Pinto-Grau; Katie Lonergan; Mark Heverin; Katy Tobin; Anthony Staines; Miriam Galvin; Niall Pender
Journal:  J Neurol       Date:  2018-02-02       Impact factor: 4.849

10.  Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS).

Authors:  Georgia Christodoulou; Chris Gennings; Jonathan Hupf; Pam Factor-Litvak; Jennifer Murphy; Raymond R Goetz; Hiroshi Mitsumoto
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-04-28       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.